[1]
“ADVERSE FETOMATERNAL OUTCOMES IN WOMEN WITH HELLP SYNDROME”, J Popl Ther Clin Pharmacol, vol. 31, no. 4, pp. 2274–2281, Apr. 2024, doi: 10.53555/mfrm8v65.